+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Branched Peptide Market by Application (Antimicrobial Therapy, Cancer Therapy, Drug Delivery), Peptide Type (Dendrimeric, Hyperbranched, Star Shaped), End User, Technology, Molecular Weight - Global Forecast 2025-2030- Product Image
Branched Peptide Market by Application (Antimicrobial Therapy, Cancer Therapy, Drug Delivery), Peptide Type (Dendrimeric, Hyperbranched, Star Shaped), End User, Technology, Molecular Weight - Global Forecast 2025-2030- Product Image
Sale

Branched Peptide Market by Application (Antimicrobial Therapy, Cancer Therapy, Drug Delivery), Peptide Type (Dendrimeric, Hyperbranched, Star Shaped), End User, Technology, Molecular Weight - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118805
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The branched peptide market is undergoing rapid transformation as pharmaceutical companies, biotech innovators, and academic collaborators increasingly adopt advanced synthesis technologies for targeted drug delivery, immunotherapy, and precision medicine. Senior decision-makers evaluating this sector will find it defined by complex architectures, agile development practices, and evolving competitive strategies.

Market Snapshot: Branched Peptide Market Overview

The landscape of therapeutic research has shifted dramatically with the emergence of branched peptides—multi-arm biomolecules prized for enhanced stability and specificity. Market expansion is driven by breakthroughs in synthesis, analytical methodologies, and cross-sector partnerships. Heightened global investment reflects strong confidence in clinical candidacy and platform versatility. The market’s value growth is underpinned by demand for advanced drug delivery solutions, innovative cancer therapies, and cutting-edge immunomodulatory agents, propelling adoption in both established and emerging regions.

Scope & Segmentation

This report delivers detailed segmentation, ensuring targeted insights for companies assessing both operational and strategic investments across the branched peptide sector:

  • Application: Antimicrobial therapy, cancer therapy, drug delivery, immunotherapy
  • Peptide Type: Dendrimeric (Generation 1, Generation 2, Generation 3 and above), Hyperbranched, Star shaped
  • End User: Academic research institutes, biotechnology companies, contract research organizations, pharmaceutical companies (large, mid tier, small)
  • Technology: Liquid phase synthesis, solid phase synthesis (Boc chemistry, Fmoc chemistry)
  • Molecular Weight: Greater than five KDa, less than one KDa, one to five KDa (including one to two KDa, two to five KDa)
  • Geographic Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Bachem Holding AG, GenScript Biotech Corporation, PeptiDream Inc., CPC Scientific Inc., Abcam plc, CordenPharma International GmbH, JPT Peptide Technologies GmbH

Key Takeaways

  • Innovation in branched peptide synthesis, such as dendrimeric and star-shaped architectures, has broadened the molecular toolkit for drug developers aiming to address complex disease pathways.
  • Strategic collaborations between academic, contract, and pharmaceutical stakeholders enhance high-throughput screening and rapid lead optimization, accelerating clinical translation.
  • Regional dynamics reveal that the Americas lead commercialization through streamlined regulatory frameworks and funding, while Europe, Middle East & Africa leverage precision design and partnerships, and Asia-Pacific focuses on manufacturing scale-up and global alliances.
  • Diverse molecular weights and synthesis preferences allow tailoring of constructs for controlled release, increased payload encapsulation, or site-specific modifications, meeting varied end-user demands.
  • Competitive advantage increasingly depends on integrated service offerings, strong supply chain resilience, and robust intellectual property management within a dynamic regulatory landscape.

Tariff Impact on the Branched Peptide Supply Chain

Recent United States tariff regulations targeting key raw materials and intermediates have significantly affected cost structures and manufacturing continuity. Companies are adapting by exploring alternative sourcing, engaging in nearshoring, and establishing long-term procurement agreements to mitigate volatility. These adjustments enhance input stability but require intensified quality oversight to uphold product consistency and regulatory compliance.

Methodology & Data Sources

Insight is derived through a combination of in-depth interviews with industry stakeholders and rigorous secondary data collection, encompassing scientific literature, patents, regulatory guidance, and validated financial disclosures. Cross-referencing and robust data triangulation ensure accuracy and actionable relevance in every finding.

Why This Report Matters

  • Enables executive teams to benchmark innovation strategies and optimize investment across key branched peptide segments.
  • Supports supply chain leaders and regulatory affairs professionals navigating tariff-induced cost pressures and quality assurance challenges.
  • Equips portfolio managers to assess the competitive positioning and partnership potential of market leaders and strategic upstarts.

Conclusion

Branched peptides are redefining paradigms in therapeutic development and drug delivery platforms. Strategic adaptability, regional diversification, and integrated partnerships will shape the next phase of growth and market impact.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in microwave-assisted synthesis techniques for high-yield branched peptide production enabling cost reduction
5.2. Growing application of branched peptide scaffolds in multimodal cancer immunotherapy platforms with enhanced targeting functions
5.3. Development of biodegradable and stimuli-responsive branched peptide hydrogels for controlled drug release in wound healing applications
5.4. Integration of branched peptides with nanoparticle carriers for precision delivery across the blood-brain barrier in neurological disease treatments
5.5. Rising demand for green chemistry protocols in branched peptide synthesis to reduce environmental impact and regulatory compliance costs
5.6. Customizable branched peptide libraries for high-throughput screening in personalized precision medicine and biomarker discovery
5.7. Innovations in computational design of branching patterns to optimize peptide stability and receptor affinity in therapeutic candidates
5.8. Expansion of branched peptide-based antimicrobial coatings for medical devices to combat antibiotic-resistant bacterial infections
5.9. Strategic partnerships between biotech startups and contract manufacturing organizations to scale branched peptide therapeutic production
5.10. Implementation of continuous flow manufacturing systems to enhance consistency and throughput of branched peptide synthesis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Branched Peptide Market, by Application
8.1. Introduction
8.2. Antimicrobial Therapy
8.3. Cancer Therapy
8.4. Drug Delivery
8.5. Immunotherapy
9. Branched Peptide Market, by Peptide Type
9.1. Introduction
9.2. Dendrimeric
9.2.1. Generation 1
9.2.2. Generation 2
9.2.3. Generation 3 And Above
9.3. Hyperbranched
9.4. Star Shaped
10. Branched Peptide Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
10.5.1. Large Pharmaceutical Companies
10.5.2. Mid Tier Pharmaceutical Companies
10.5.3. Small Pharmaceutical Companies
11. Branched Peptide Market, by Technology
11.1. Introduction
11.2. Liquid Phase Synthesis
11.3. Solid Phase Synthesis
11.3.1. Boc Chemistry
11.3.2. Fmoc Chemistry
12. Branched Peptide Market, by Molecular Weight
12.1. Introduction
12.2. Greater Than Five KDa
12.3. Less Than One KDa
12.4. One To Five KDa
12.4.1. One To Two KDa
12.4.2. Two To Five KDa
13. Americas Branched Peptide Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Branched Peptide Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Branched Peptide Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Lonza Group AG
16.3.4. Bachem Holding AG
16.3.5. GenScript Biotech Corporation
16.3.6. PeptiDream Inc.
16.3.7. CPC Scientific Inc.
16.3.8. Abcam plc
16.3.9. CordenPharma International GmbH
16.3.10. JPT Peptide Technologies GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRANCHED PEPTIDE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRANCHED PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRANCHED PEPTIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRANCHED PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRANCHED PEPTIDE MARKET: RESEARCHAI
FIGURE 26. BRANCHED PEPTIDE MARKET: RESEARCHSTATISTICS
FIGURE 27. BRANCHED PEPTIDE MARKET: RESEARCHCONTACTS
FIGURE 28. BRANCHED PEPTIDE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRANCHED PEPTIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRANCHED PEPTIDE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRANCHED PEPTIDE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ANTIMICROBIAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ANTIMICROBIAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY CANCER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GENERATION 1, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GENERATION 1, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GENERATION 2, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GENERATION 2, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GENERATION 3 AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GENERATION 3 AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY HYPERBRANCHED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY HYPERBRANCHED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY STAR SHAPED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY STAR SHAPED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY MID TIER PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY MID TIER PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY SMALL PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY SMALL PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY LIQUID PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GREATER THAN FIVE KDA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY GREATER THAN FIVE KDA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY LESS THAN ONE KDA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY LESS THAN ONE KDA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO TWO KDA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO TWO KDA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY TWO TO FIVE KDA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY TWO TO FIVE KDA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BRANCHED PEPTIDE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 124. CANADA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 125. CANADA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 128. CANADA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 129. CANADA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. CANADA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. CANADA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 132. CANADA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 133. CANADA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 134. CANADA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 135. CANADA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 136. CANADA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BRANCHED PEPTIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 229. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 234. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 235. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 238. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 239. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 242. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 243. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 244. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 245. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 246. GERMANY BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 247. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 252. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 253. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 256. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 257. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 260. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 261. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 262. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 263. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 264. FRANCE BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 283. ITALY BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 288. ITALY BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 289. ITALY BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. ITALY BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 292. ITALY BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 293. ITALY BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. ITALY BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. ITALY BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 296. ITALY BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 297. ITALY BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 298. ITALY BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 299. ITALY BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 300. ITALY BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 301. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 304. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 305. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 306. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 307. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 310. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 311. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 314. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 315. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 316. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 317. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 318. SPAIN BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES BRANCHED PEPTIDE MARKET SIZE, BY ONE TO FIVE KDA, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA BRANCHED PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA BRANCHED PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA BRANCHED PEPTIDE MARKET SIZE, BY DENDRIMERIC, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA BRANCHED PEPTIDE MARKET SIZE, BY DENDRI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Branched Peptide market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group AG
  • Bachem Holding AG
  • GenScript Biotech Corporation
  • PeptiDream Inc.
  • CPC Scientific Inc.
  • Abcam plc
  • CordenPharma International GmbH
  • JPT Peptide Technologies GmbH

Related Reports

Peptide Antibody Conjugate Market by Linker Type (Cleavable, Non Cleavable), Therapeutic Area (Cardiovascular, Infectious Diseases, Oncology), End User, Peptide Type, Route of Administration, Conjugation Technology - Global Forecast 2025-2030 - Product Image

Peptide Antibody Conjugate Market by Linker Type (Cleavable, Non Cleavable), Therapeutic Area (Cardiovascular, Infectious Diseases, Oncology), End User, Peptide Type, Route of Administration, Conjugation Technology - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Cardiac Targeting Peptides Market by Product Type (Diagnostics Peptides, Dual Function Peptides, Therapeutic Peptides), Application (Diagnostic Imaging, Targeted Drug Delivery, Therapeutic Treatment), End User, Delivery System, Molecule Type - Global Forecast 2025-2030 - Product Image

Cardiac Targeting Peptides Market by Product Type (Diagnostics Peptides, Dual Function Peptides, Therapeutic Peptides), Application (Diagnostic Imaging, Targeted Drug Delivery, Therapeutic Treatment), End User, Delivery System, Molecule Type - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Cell Penetrating Peptide Market Report 2025 - Product Image

Cell Penetrating Peptide Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Branched Chain Amino Acid (BCAA) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Branched Chain Amino Acid (BCAA) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Maple Syrup Urine Disease- Pipeline Insight, 2025 - Product Image

Maple Syrup Urine Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.